ASLAN Pharmaceuticals Statistics
Total Valuation
ASLN has a market cap or net worth of $1.70 million. The enterprise value is $9.97 million.
| Market Cap | 1.70M |
| Enterprise Value | 9.97M |
Important Dates
The last earnings date was Friday, August 9, 2024, before market open.
| Earnings Date | Aug 9, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ASLN has 2.83 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 2.83M |
| Owned by Insiders (%) | 0.14% |
| Owned by Institutions (%) | 13.21% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.14 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.83 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.05
| Current Ratio | 1.05 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -7.90 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -96.30% |
| Return on Invested Capital (ROIC) | -401.40% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | $342,857 |
| Profits Per Employee | -$1.00M |
| Employee Count | 35 |
| Asset Turnover | 0.33 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ASLN has paid $126,074 in taxes.
| Income Tax | 126,074 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -97.15% in the last 52 weeks. The beta is 1.40, so ASLN's price volatility has been higher than the market average.
| Beta (5Y) | 1.40 |
| 52-Week Price Change | -97.15% |
| 50-Day Moving Average | 2.61 |
| 200-Day Moving Average | 4.85 |
| Relative Strength Index (RSI) | 21.69 |
| Average Volume (20 Days) | 284,891 |
Short Selling Information
| Short Interest | 306,565 |
| Short Previous Month | 269,900 |
| Short % of Shares Out | 1.46% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1.85 |
Income Statement
In the last 12 months, ASLN had revenue of $12.00 million and -$35.03 million in losses. Loss per share was -$14.00.
| Revenue | 12.00M |
| Gross Profit | 12.00M |
| Operating Income | -34.92M |
| Pretax Income | -34.90M |
| Net Income | -35.03M |
| EBITDA | n/a |
| EBIT | -30.98M |
| Loss Per Share | -$14.00 |
Balance Sheet
The company has $18.40 million in cash and $26.67 million in debt, giving a net cash position of -$8.27 million or -$2.92 per share.
| Cash & Cash Equivalents | 18.40M |
| Total Debt | 26.67M |
| Net Cash | -8.27M |
| Net Cash Per Share | -$2.92 |
| Equity (Book Value) | -17.96M |
| Book Value Per Share | -6.35 |
| Working Capital | 972,048 |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 100.00%, with operating and profit margins of -291.03% and -291.89%.
| Gross Margin | 100.00% |
| Operating Margin | -291.03% |
| Pretax Margin | -290.84% |
| Profit Margin | -291.89% |
| EBITDA Margin | n/a |
| EBIT Margin | -258.15% |
| FCF Margin | n/a |
Dividends & Yields
ASLN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -25.91% |
| Shareholder Yield | -25.91% |
| Earnings Yield | -2,064.03% |
| FCF Yield | n/a |
Analyst Forecast
The average price target for ASLN is $90.67, which is 15,011.67% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $90.67 |
| Price Target Difference | 15,011.67% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 3, 2024. It was a reverse split with a ratio of 1:8.
| Last Split Date | Jul 3, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:8 |
Scores
ASLN has an Altman Z-Score of -26.3 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -26.3 |
| Piotroski F-Score | 1 |